Scientifice Programme
Wednesday 15 April 2026
Time
Auditorium 1
Auditorium 2
09:00 – 10:00
P01. Opening 9th WoCoVA
P01.1 Welcome – Jacoline Zilverentant (NL)
P01.2 Basic information about the congress – Toine Hulshof (NL)
P01.3 Welcome from SEIVAV president – Elizabeth Lafuente Cabrero (ES)
P01.4 Opening words WoCoVA president – Tim Spencer (US)
P01.5 Keynote – Intravascular catheters and their role in history
Emilio Bouza (ES)
10:00 – 11:00
S01. The Skin Session
Chairs: Lieve Goossens (BE) and
Gloria Ortiz Miluy (ES)
S01.1 MARSI and CASI: the state of the art
Christian Dupont (FR)S01.2 The challenge of skin in hematology patients
Nancy Moureau (US)
Abstract Presentation
S01.3 Construction and application of decision support tool for venous catheter in lymphoma patients
Yang He (CN)
Discussion
S13. The Tunnel Session
Chairs: Adam Fabiani (IT) and Amy Bardin (US)
S13.1 Tunneled, non-cuffed catheter: a new device or a technical variant?
Davide Giustivi (IT)S13.2 Indications for tunnelling CVAD and Midline in clinical practice
Matthew Ostroff (US)
Abstract Presentation
S13.3 Impact of Subcutaneous Tunneling on Peripherally Inserted Central Catheter–Related Complications
Wei Gao (CN)
Discussion
11:00 – 12:00
S02. The Port Session
Chairs: Maria Giuseppina Annetta (IT) and Evan Alexandrou (AU)
S02.1 The PICC port as first option in oncology patients
Sergio Bertoglio (IT)S02.2 The current state of the art of port insertion
Fulvio Pinelli (IT)
Abstract Presentation
S02.3 Breast cancer as a low-risk subgroup for PICC-port complicationsDiscussion
Pascal Fangio (FR)
S14. The Virtual Sedation Session
Chairs: Stefano Elli (IT) and Jiri Charvat (CZ)
-
S14.1 Non-pharmacological approach for reducing patient’s anxiety
Jose Daniel Jiminéz Santana (ES) -
S14.2 Virtual sedation today: what evidence of efficacy?
Hervé Rosay (FR)
Abstract Presentation
-
S14.3 Using Virtual Reality to manage Needle Phobia in Emergency Department
Grace Xu (CN)
Discussion
13:00 – 14:00
3 Industry symposia
14:00 – 15:00
S03. The Malfunction Session
Chairs: Victoria Armenteros Yeguas (ES) and Amit Bahl (US)
So3.1 Defining malfunction and occlusion
Lieve Goossens (BE)S03.2 Management of persistent withdrawal occlusion
Sonia D’Arrigo (IT)
Abstract Presentation
S03.3 Ultrasound to Predict Radial Artery Catheterization failure in patients undergoing major cardiovascular surgery
Jerome Paniego (FR)
Discussion
S15. The Material Session
Chairs: Giancarlo Scoppettuolo (IT) and Giovanni Barone (IT)
S15.1 What are we talking about when we talk about power injectability
Sergio Bertoglio (IT)S15.2 Antimicrobial and antithrombotic catheters: do they work?
Amanda Ullman (AU)
Abstract Presentation
S15.3 Vascular access device selection in internal medicine wards: a complex world
Alba Taino (IT)
Discussion
15:40 – 17:00
S04. Choosing the VAD Session
Chairs: Hervé Rosay (FR) and Nancy Moureau (US)
S04.1 The Choice of VAD in adult patients
Adam Fabiani (IT)S04.2 The choice of VAD in children
Alessandro Crocoli (IT)S04.3 External catheters vs ports in cancer patients
Mauro Pittiruti (IT)
Abstract Presentation
S04,4 Global central venous access device practices in children with blood disorders and cancer
Sabrina de Souza (AU)
DiscussionS
S16. The Insertion Bundles Session
Chairs: Antonio Gidaro (IT) and Michelle DeVries (US)
S16.1 The current bundles for PICC, CICC and FICC insertion
Fabrizio Brescia (IT)S16.2 The current bundles for port insertion
Maria Giuseppina Annetta (IT)S16.3 An overview of current bundles for infection prevention
Maria Guembe (ES)
Abstract Presentation
S16.4 Peri- and postoperative outcomes of totally implantable vascular access devices in babies and toddlers
Thomas Douchy (BE)
Discussion
17:00 – 18:00
S05. The Home Care Session
Chairs: Ton van Boxtel (NL) and Sonia Casanova Vivas (ES)
S05.1 Optimizing VAD insertion and maintenance in home care patients
Gloria Ortiz Miluy (ES)S05.2 Optimizing patient’s comfort and safety in home care treatments
Christian Dupont (FR)
Abstract Presentation
S05.3 Cochrane Systematic Review of Vascular Access Devices for Prolonged Intravenous Systemic Anti-Cancer Therapy in Adults with Cancer
Caitriona Duggan (IE)
Discussion
S17. The Lock Session
Chairs: Fabrizio Brescia (IT) and Marc Stranz (US)
S17.1 Anticoagulant lock in 2026: which and when
Marcia Ryder (US)S17.2 Antibacterial lock in 2026: which and when
Giancarlo Scoppettuolo (IT)
Abstract Presentation
S17.3 A triple-blinded, multi-center, cluster-randomized, crossover trial of central venous access device locking with 4% tetrasodium EDTA in the adult critical care population
Marlena Ornowska (CA)